Read more

December 29, 2021
2 min read
Save

Top endocrine news of 2021: Semaglutide approval, Walmart insulin and more

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The Healio and Endocrine Today Editors have compiled the top endocrinology news of 2021.

Readers were most interested in the FDA approval of semaglutide, Walmart launching the first private brand analogue insulin, how diet and exercise influence glucose and cardiovascular risk, and more.

phone in person's hands next to cup of coffee
Source: Adobe Stock

Here are 10 of Healio’s most-read endocrine news stories from 2021.

FDA approves once-weekly semaglutide for weight loss

The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with overweight and at least one weight-related condition.

Read

Walmart launches first and only private brand analogue insulin

Walmart announced it will partner with Novo Nordisk to launch a first-ever private brand analogue insulin, retailing up to 75% off the cash price of branded insulin products.

Read

Intermittent very low-calorie diet lowers glucose levels in adults with obesity, diabetes

Adults with obesity and type 2 diabetes improved glucose levels after eating a very low-calorie diet either 2 or 4 days per week.

Read

Metabolic syndrome ‘better prognostic indicator’ for severe COVID-19 outcomes

The odds for severe COVID-19 outcomes are increased for patients with metabolic syndrome, according to a study published in the Journal of Diabetes.

Read

Any physical activity improves CV fitness; timing may play role

The timing of moderate to vigorous physical activity bouts may improve cardiorespiratory fitness for adults with type 2 diabetes and obesity, especially for men, according to an analysis of Look AHEAD study data.

Read

Time-restricted eating may help prevent, manage many cardiometabolic diseases

Adopting a time-restricted eating schedule to align with a person’s circadian clock could help prevent diabetes, heart disease and other diseases.

Read

Vegan diet provides most health benefits among plant-based eating patterns

Vegetarian and vegan diets provide greater reductions in body weight, fat mass and LDL cholesterol and improved insulin sensitivity compared with other plant-based eating patterns, such as a Mediterranean diet.

Read

Moderate physical activity may prevent fractures for middle-aged adults

Even moderate levels of leisure-time physical activity in middle age are associated with lower risk for fractures.

Read

Novel obesity classifications can aid in tailoring weight-loss treatments

Phenotype-guided obesity interventions, determined by a blood test, can double weight loss for patients compared with standard obesity care.

Read

Experts issue ‘call to action’ to prepare for NASH epidemic

Eight professional societies issued a joint report on the dangers associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis, calling on clinicians to work together across specialties and align treatment strategies.

Read